Jennifer Gordon, MD
Gynecologic Oncology · Eugene, ORNPI 1417362914
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,297 of the $3,598 with a category attached, or 63.8%. Intuitive Surgical accounts for 93.2% of it on its own, with 4 other manufacturers making up the rest.
Across 23 payments — averaging $156.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- GSK$107
- Johnson & Johnson$97
- AstraZeneca$26
- Seagen Inc.$17
What the payments were for
- Travel & lodging$2,29764%
- Food & beverage$2758%
- Education$1,02629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $3,352 |
| GSK | 1 | $107 |
| Johnson & Johnson | 1 | $97 |
| AstraZeneca | 1 | $26 |
| Seagen Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,027
- DAVINCI XI$1,000
- ZEJULA$107
How this compares
$3,598 in reported general payments places this provider in the 60th percentile of 25 gynecologic oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 41 | $23,507 |
| Dexamethasone | 16 | $329 |
| Ondansetron Hcl | 18 | $308 |
| Megestrol Acetate | 11 | $174 |
| Oxycodone Hcl | 56 | $119 |
| Prochlorperazine Maleate | 11 | $102 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Eugene
- Audrey GarrettEugene$41K
- Charles AndersonEugene$26K
- Kathleen YangEugene$1K
- William WinterTigard$30K
- Christopher DarusPortland$24K
- Tanja PejovicPortland$17K
- Gina WesthoffPortland$16K
- Kathryn McGoniglePortland$9K
- Elizabeth MunroPortland$8K
- Amanda BrueglPortland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.